FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Antibiotic Collaboration and Licensing Deals Trends and Analysis Report 2024: Access 133 Agreements Signed by the World's Leading Biopharma Companies
The "Antibiotic Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Antibiotic Collaboration and Licensing Deals provides a comprehensive ...